STING1 and neoplasm: To counteract these detrimental conditions, the use of STING (stimulator of interferon genes) agonists reduces bone cancer–induced pain and, equally important, through the induction of the STING/IFN-1 signaling, allows protection against bone destruction and tumor growth (Wang et al., 2021).